Kalischer A L, Johnson L L, Johnson Y E, Stone J, Feder J L, Escala E, Cannon P J
J Am Coll Cardiol. 1984 Jan;3(1):210-8. doi: 10.1016/s0735-1097(84)80450-7.
The hemodynamic effects of beta-receptor blocking agents on the ejection fraction of patients with coronary artery disease during exercise have been studied previously using radionuclide techniques. Left ventricular volume measurements and the peak systolic pressure/end-systolic volume (PSP/ESV) index have been shown to be variables of left ventricular function that are less influenced by preload and afterload than is ejection fraction. Left ventricular volumes and PSP/ESV were therefore measured in 18 patients with proven coronary artery disease in the control state and after 2 weeks of daily maintenance therapy with either 240 mg propranolol or 60 mg timolol. Values at rest and during symptom-limited upright exercise were compared using the first pass technique and a multicrystal scintillation camera. Left ventricular volumes were measured by the area-length method. Because there was no difference between the propranolol and timolol groups, the results for both groups were combined. The ejection fraction at rest after beta-receptor blocker treatment was not significantly different from pretreatment measurements because of an increase in both end-diastolic and end-systolic volumes (p less than 0.01). However, the value for peak systolic pressure/end-systolic volume (PSP/ESV) index at rest was lower after treatment. The exercise ejection fraction was greater after treatment (p less than 0.01), owing to an increase in end-diastolic volume and unchanged end-systolic volume. In addition, there was a significant improvement in the directional change in the PSP/ESV ratio between rest and exercise from pretreatment to treatment (-1.1 +/- 2.5 to +0.2 +/- 1.2, p less than 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)
以往曾采用放射性核素技术研究β受体阻滞剂对冠心病患者运动期间射血分数的血流动力学效应。左心室容积测量以及收缩压峰值/收缩末期容积(PSP/ESV)指数已被证明是左心室功能的变量,与射血分数相比,它们受前负荷和后负荷的影响较小。因此,对18例经证实患有冠心病的患者在对照状态下以及在用240mg普萘洛尔或60mg噻吗洛尔进行每日维持治疗2周后,测量了左心室容积和PSP/ESV。使用首次通过技术和多晶体闪烁相机比较了静息状态和症状限制直立运动期间的值。左心室容积通过面积-长度法测量。由于普萘洛尔组和噻吗洛尔组之间没有差异,将两组结果合并。β受体阻滞剂治疗后静息时的射血分数与治疗前测量值无显著差异,因为舒张末期和收缩末期容积均增加(p<0.01)。然而,治疗后静息时的收缩压峰值/收缩末期容积(PSP/ESV)指数值较低。治疗后运动射血分数更高(p<0.01),这是由于舒张末期容积增加而收缩末期容积不变。此外,从治疗前到治疗后,静息和运动之间PSP/ESV比值的方向变化有显著改善(从-1.1±2.5到+0.2±1.2,p<0.02)。(摘要截短于250字)